Table 2.
Summary of the expressions of BTLA/HVEM/LIGHT/CD160 on CD4+, CD8+ and CD19+ lymphocytes.
| BTLA (%) | HVEM (%) | LIGHT (%) | CD160 (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CD4+ | CD8+ | CD19+ | CD4+ | CD8+ | CD19+ | CD4+ | CD8+ | CD19+ | CD4+ | CD8+ | CD19+ | |
| BPAR | 91.41 ± 1.40** | 94.60 ± 1.63 | 82.58 ± 2.34 | 75.37 ± 3.72 | 69.50 ± 4.14 | 63.67 ± 3.40 | 4.90 ± 0.56 | 8.08 ± 3.22 | 1.91 ± 1.49 | 5.77 ± 1.06 | 38.53 ± 3.81* | 10.78 ± 1.32 |
| Stable | 98.19 ± 0.72 | 98.10 ± 0.46 | 83.90 ± 1.79 | 70.64 ± 4.86 | 62.90 ± 6.69 | 62.70 ± 5.49 | 4.71 ± 0.51 | 4.15 ± 1.13 | 3.059 ± 2.29 | 7.87 ± 1.05 | 55.84 ± 5.10 | 13.55 ± 1.54 |
| Healthy volunteers | 84.66 ± 1.76## | 85.00 ± 2.39## | 72.04 ± 3.87# | 71.58 ± 2.53 | 55.96 ± 6.09 | 67.33 ± 6.63 | 4.15 ± 0.48 | 5.15 ± 1.19 | 2.22 ± 0.30 | 5.26 ± 0.75 | 36.38 ± 4.97# | 9.74 ± 1.59 |
*
P<0.05;
**
P<0.001;
#
P<0.05;
##
P<0.0001.
BTLA – B- and T-lymphocyte attenuator; HVEM – herpes virus entry mediator; LIGHT – lymphotoxin; BPAR – biopsy-proven acute rejection.